Pegvisomant

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 648 publications

Hyperprolactinaemia masked by the hook effect in a patient with a giant prolactinoma with growth hormone co-secretion.

Hyperprolactinaemia masked by the hook effect in a patient with a giant prolactinoma with growth hormone co-secretion.

Journal: BMJ case reports

Published: July 13, 2026

Acromegaly Secondary to Ectopic Growth Hormone-Releasing Hormone Secretion From Metastatic Bronchial Carcinoid Tumor: A Case Report.

Acromegaly Secondary to Ectopic Growth Hormone-Releasing Hormone Secretion From Metastatic Bronchial Carcinoid Tumor: A Case Report.

Journal: Cureus

Published: July 09, 2026

Authors' reply to the letter to the editor by Fedai et al.: "Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort".

Authors' reply to the letter to the editor by Fedai et al.: "Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort".

Journal: Pituitary

Published: June 17, 2026

Acromegaly and Metabolic Dysfunction-Associated Steatotic Liver Disease: Clinical and Therapeutic Implications.

Acromegaly and Metabolic Dysfunction-Associated Steatotic Liver Disease: Clinical and Therapeutic Implications.

Journal: Current obesity reports

Published: June 09, 2026

Reassuring long-term data on efficacy and safety of pegvisomant monotherapy in a large series of patients with acromegaly.

Reassuring long-term data on efficacy and safety of pegvisomant monotherapy in a large series of patients with acromegaly.

Journal: Pituitary

Published: May 29, 2026

Impact of endoscopy and related technologies on indications for transsphenoidal pituitary surgery for growth hormone-producing pituitary neuroendocrine tumors in McCune-Albright syndrome: illustrative case.

Impact of endoscopy and related technologies on indications for transsphenoidal pituitary surgery for growth hormone-producing pituitary neuroendocrine tumors in McCune-Albright syndrome: illustrative case.

Journal: Journal of neurosurgery. Case lessons

Published: May 24, 2026

Injection-Site Sarcomas in Rodent Carcinogenicity Studies: Human Relevance and Labeling Implications.

Injection-Site Sarcomas in Rodent Carcinogenicity Studies: Human Relevance and Labeling Implications.

Journal: Toxicologic pathology

Published: May 12, 2026

Development and Characterization of a Long-Acting Allosteric Growth Hormone Receptor Antagonist for Acromegaly.

Development and Characterization of a Long-Acting Allosteric Growth Hormone Receptor Antagonist for Acromegaly.

Journal: Endocrinology

Published: May 12, 2026

Can acromegaly be controlled in all cases?

Can acromegaly be controlled in all cases?

Journal: Journal of neuroendocrinology

Published: May 08, 2026

Genome architecture in endocrine diseases: X-Linked Acrogigantism (X-LAG) syndrome.

Genome architecture in endocrine diseases: X-Linked Acrogigantism (X-LAG) syndrome.

Journal: Annales d'endocrinologie

Published: May 08, 2026

Management and safety of somatostatin receptor ligands and pegvisomant in pregnant women with acromegaly: a narrative review of the literature.

Management and safety of somatostatin receptor ligands and pegvisomant in pregnant women with acromegaly: a narrative review of the literature.

Journal: Endocrine

Published: May 04, 2026

High-yield soluble expression and affinity-tag-free purification of growth hormone receptor antagonist B2036 in Escherichia coli.

High-yield soluble expression and affinity-tag-free purification of growth hormone receptor antagonist B2036 in Escherichia coli.

Journal: Bioprocess and biosystems engineering

Published: April 28, 2026

Showing 1-12 of 648

Last Updated: 09/26/2026